FALLOPIAN TUBE CARCINOSARCOMA
Clinical trials for FALLOPIAN TUBE CARCINOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE CARCINOSARCOMA trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine combo shows promise in ovarian cancer fight
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own white blood cells, combined with an immunotherapy drug (pembrolizumab), for people with ovarian cancer that has returned. The vaccine targets a protein found on many ovarian cancer cells, training the immune system…
Matched conditions: FALLOPIAN TUBE CARCINOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 02:18 UTC
-
Promising combo therapy targets fluid buildup in recurrent ovarian cancer
Disease control Recruiting nowThis study tests whether adding an experimental drug (APL-2) to standard immunotherapy (pembrolizumab) and/or a targeted therapy (bevacizumab) can better control fluid buildup and tumor growth in people whose ovarian, fallopian tube, or peritoneal cancer has returned. About 60 ad…
Matched conditions: FALLOPIAN TUBE CARCINOSARCOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New vaccine aims to keep ovarian cancer at bay
Disease control Recruiting nowThis study tests a vaccine made from a patient's own white blood cells, designed to train the immune system to attack ovarian cancer cells. It is for people with advanced stage III or IV ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see if the vaccine can …
Matched conditions: FALLOPIAN TUBE CARCINOSARCOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 11, 2026 20:41 UTC